day 1 agenda

World Congress on Vaccines
July 10-11, 2025 @ Vienna, Austria
Meeting Hall - Karl Kraus+ Siegfried Marcus
08:20-09:00                                            Registrations 
09:00-09:10                            Welcome Remarks by Moderator
Moderator: Júlia Vergara-Alert, Institute of Agrifood Research and Technology, Spain
Keynote Talks
Liang Zhou, University of Florida, USA 09:10-09:40 The role of Innate Lymphoid Cells in Mucosal Infection
Monica Lahra, NSW Health Pathology, Australia 09:40-10:10 Multidrug resistant N. gonorrhoeae
Ying Liao, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China 10:10-10:40 Coronavirus Nucleocapsid Protein Enhances p-PKCα Binding to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Group Photo & Refreshment Break (10:40-11:00)
Technical Session-I 
Session Chair : Liang Zhou, University of Florida, USA
Jooeun Bae, Harvard Medical School, USA 11:00-11:20 Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine
Sina Bavari, Tonix Pharmaceuticals Holding Corp, USA 11:20-11:40 TNX-801, a single-dose live vaccine platform for Mpox and other emerging viral diseases Safety, Immunogenicity, and Efficacy
Balázs Rada, The University of Georgia, USA 11:40-12:00 Opportunities for targeting neutrophils to increase vaccine efficacy
Tian Wang, University of Texas Medical Branch, USA 12:00-12:20 Development of safe and efficacious vaccines against emerging arboviruses
Lina Souan, King Hussein Cancer Center, Jordan 12:20-12:40 Effectiveness and Duration of Anti-RBD SARS-CoV-2 IgG Response Across Vaccines: Implications for Vaccine Strategies
Shin, Yeun-Kyung, Animal and Plant Quarantine Agency, South Korea 12:40-13:00 Propagation of porcine reproductive and respiratory syndrome virus increases in PRRSV-susceptible porcine kidney cells modifying LGP2 and RIG-I
Lunch Break @ Restaurant (13:00-14:00)
Technical Session-II
Session Chairs: Monica Lahra, NSW Health Pathology, Australia
Maja Mockenhaupt, University of Freiburg, Germany 14:00-14:20 Infections as possible trigger of epidermal necrolysis
Hamsa Taher Tayeb, King Faisal Specialist Hospital & Research Center, Saudi Arabia 14:20-14:40 Implementation of Next Generation Sequencing (NGS) as a Diagnostic Tool in Infectious Diseases
Polona Kogovšek, National institute of biology, Slovenia 14:40-15:00  Evaluation of the antiviral activity of compounds using computational, bioassay, molecular biology and electron microscopy techniques
Emmanuel Mintah Bonku, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China 15:00-15:20 Progress in antiviral drug R&D, and API manufacturing via industrial-grade ‘control from root design’ concept
Ximeng Han, University of Oxford, United Kingdom 15:20-15:40 Preclinical Development of a Bivalent Malaria Transmission-Blocking Vaccine
Alessia Arcaro, University of Molise, Italy 15:40-16:00 Amhiphilic and ganglioside-binding properties of SARS-CoV-2 Spike glycoprotein variants dissected by charge-shift electrophoresis in detergent solution
Refreshment Break (16:00-16:20)
Poster Presentations(16:20-16:50)
Pooja Goel, The Lyndhurst Surgery, UK P1 Barriers to the Flu Vaccination: Patients’ Perspective within a London GP
Baek Kim, Vernagen LLC, USA P2 Immunogenicity and protective efficacy of Respiratory Syncytial Virus mRNA vaccine encoding the F protein of both RSV subtypes A and B in a BALB/c mouse model
Szu-Hao Kung, National Yang Ming Chiao Tung University, Taiwan P3 Development of ionophore antibiotics as antiviral agents against enteroviruses and coronaviruses
Pannel Discussions & Closing Ceremony

day 2 agenda

Day-2 (July 11, 2025) 
Moderator: Tian Wang, University of Texas Medical Branch, USA
Keynote Talks
Jerald Sadoff, Centivax Inc, USA 09:30-10:00 Universal vaccines against influenza and other pathogens
Taijiao Jiang, Guangzhou National Laboratory, China 10:00-10:30 Predicting Influenza Virus Antigenic Variation and Vaccine Strains with PREDAC
Xiufen Zheng, Western University, Canada 10:30-11:00 Potentials and challenges of circular RNA as a therapy/vaccine  in treating diseases 
Refreshment Break (11:00-11:20)
Technical Session-III
Session Chairs:
Xiufen Zheng, Western University, Canada              
Jerald Sadoff, Centivax Inc, USA
Lorrin Pang, Hawaii Dept of Health, USA 11:20-11:40 Accurately monitoring the effect of intervention tools during a pandemic (fixing the plane “while it’s flying")
Júlia Vergara-Alert, Institute of Agrifood Research and Technology, Spain 11:40-12:00 Zoo-in-a-dish. How organoids are reshaping zoonotic disease research
João Luis Garcia, Londrina State University, Spain 12:00-12:20 Vaccines against Toxoplasma gondii: the past, the present and the future
Yoon-Hee Lee, Animal and Plant Quarantine Agency, South Korea 12:20-12:40 The appication of Nano-Luciferase based biosensor for the detection of FMDV(Foot and Mouth Disease Virus) type Asia1
I Y Saleem, Liverpool John Moores University, UK 12:40-13:00 Inhalable Nanovaccine Targeting Pneumococcal Proteins for Lung Protection
Ximeng Han, Jenner Institute, University of Oxford, UK 13:00-13:20 Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine
Lunch Break @ Restaurant (13:20-14:20)
Day 2 Concludes

World Congress on Vaccines
July 10-11 @ Vienna, Austria
Scientific Program
Virtual Program
July 11, 2025, Central European Time (CET)
Virtual Presentation Through ZOOM
10:30-10:50 A self-adjuvanted protein nanoparticle that stimulates Ultra-High affinity antibodies 
Ming-Chung Kan, Vaxsia Biomedical Inc, Taiwan
   
10:50-11:10 Synergistic effect of attenuated Toxoplasma gondii NRTUA strain and biological drug therapy: Reprogramming tumor microenvironment and inhibiting tumor growth in pancreatic cancer
Xingwang Zhou, Sun Yat-Sen University Zhongshan School of Medicine, China
   
11:10-11:30 Broad-spectrum antiviral peptide studies against respiratory viruses
Hanjun ZHAO, Fudan University , Taiwan
   
11:30-11:50 Immune correlates of Dengue protection and pathogenesis in pediatric Dengue infected patients
Anuja Krishnan, Jamia Hamdard University, India
   
11:50-12:10 Post-vaccine immune status surveillance of Covishield vaccine and associated AEFI in previously SARS-Cov-2 infected seropositive and seronegative population in Assam
Gogoi, Gayatri, Assam Medical College and Hospital, India
   
12:10-12:30 The influence of Anti-SARS-CoV-2 Vaccines on the Cytokine Responses of Peripheral Blood Mononuclear Cells and Neutrophils from Individuals Vaccinated with Pfizer and AstraZeneca
Sahar Sultan Essa, Kuwait University, Kuwait
   
12:30-12:50 Does Delivery Matter? Examining Pandemic Vaccination Preferences across Time and Countries Using a Discrete Choice Experiment
Cynthia Qingxia Kong, Erasmus University, Netherlands 
   
12:50-13:20 Keynote: Possible mechanisms of centenarian resilience to COVID-19
Calogero Caruso, University of Palermo, Italy
   
13:20-13:40 Analysis of the expectations of patients with hepatitis c virus towards family doctors
Lidia El?bieta Sierpi?ska, Military Clinical Hospital, Poland
   
13:40-14:00 Grassroots Mobilisation: Leveraging Civil Society and Community Leadership to Bridge Gaps in Vaccine Coverage
Mariano Votta, Responsible EU Affairs at Cittadinanzattiva, Italy
   
14:00-14:20 Cwp2 as a vaccine candidate protects mice against Clostridioides difficile infection
Xingmin Sun, University of South Florida, Uk
   
14:20-14:50 Keynote: Tuberculosis vaccination needs to avoid ‘decoy’ immune reactions
Juraj Ivanyi, Kings College London, UK
   
14:50-15:10 TBA
Gisela Freitas Trindade, Oswaldo Cruz Foundation, Brazil
   
15:10-15:30 The relationship between immunogenicity and reactogenicity of seasonal influenza vaccine using different delivery methods
Daniel Gromer, Emory University School of Medicine, United States
   
15:30-16:00 Keynote: Mpox Outbreaks: Poxvirus Virulence Studies and Vaccine Development
Rachel Roper, East Carolina University, Brody Medical School, USA
   
16:00-16:30 Keynote: Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice
Nisha J Garg, Washington University, USA
   
16:30-16:50 The neuroimmune mechanisms underlying SARS-CoV-2-induced post
acute sequelae of COVID-19
Jianyang Du, University of Tennessee Health Science Center, USA
   
16:50-17:10 Assessing Biofilm at the Bedside: Exploring Reliable Accessible Biofilm Detection Methods
Laura Jones Donaldson, MolecuLight, Canada
   
17:10-17:40 Keynote: Critical Role of Relative Humidity in the Survival and Transmission of Airborne Viruses
Richard N. Zare, Stanford University, Stanford, USA
Day concludes

Download